Skip to content

Detection of CardioRespiratory Events Using Acoustic Monitoring in Preterm Infants on CPAP

Apnea of Prematurity

This is an observational, proof-of-concept, feasibility study where 50 preterm infants with gestational age \< 32+0 weeks will be recruited from the neonatal intensive care unit (NICU) at the Montreal Children's Hospital.

The study's primary objective is to describe the relationship between respiratory acoustics and airflow and determine the reliability of a novel respiratory acoustic sensor at detecting breathing sounds in preterm infants.

The study's secondary objectives are:

1. To compare transthoracic impedance, respiratory inductive plethysmography and an inertial measurement unit for the detection of respiratory efforts in preterm infants.
2. To evaluate the feasibility and accuracy of a novel, non-invasive method for continuously detecting and differentiating cardiorespiratory events in preterm infants on CPAP by integrating measurements of respiratory effort with respiratory acoustic monitoring.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    72 and up

Participation Criteria

Inclusion Criteria for all infants:

* Gestational age \< 32+0 weeks
* Postmenstrual age between 28+0 and 36+6 weeks.

Additional inclusion criteria for Groups 1 and 2:

* Off any respiratory support and breathing in-room air
* Less than 3 clinically significant cardiorespiratory events per calendar day

Additional inclusion criteria for Group 3:

* On the bubble CPAP device with the binasal prongs interface
* Receiving CPAP levels of 5 to 7 cm H2O with gas flows not exceeding 10L/min
* At least 3 clinically significant cardiorespiratory events per calendar day

Exclusion Criteria:

* Major known congenital abnormalities
* Known congenital heart disorders
* Known neuromuscular disease
* Known diaphragmatic paralysis or a diagnosed phrenic nerve injury
* History of esophageal perforation in the 7 days preceding the study
* History of pneumothorax requiring chest tube insertion in the 7 days preceding the study
* Receiving inotropes, narcotics, or sedative agents at the time of study recording

Additional exclusions at the time of the study recording:

* Infants receiving ventilator-derived CPAP
* Infants receiving CPAP via a nasal mask interface.
* Infants receiving inotropes, narcotics or sedative agents
* Infants deemed clinically unstable for the study by the attending neonatologist.

Study Location

McGill University Health Center
McGill University Health Center
Montreal, Quebec
Canada

Contact Study Team

Backup Contact

Wissam Shalish, MD PhD

Primary Contact

Wissam Shalish, MD, PhD

[email protected]
514-412-4400
Backup Contact

Guilherme Sant'Anna, MD PhD

Backup Contact

Robert E Kearney, PhD

Study Sponsored By
McGill University Health Centre/Research Institute of the McGill University Health Centre
Participants Required
More Information
Study ID: NCT05196646